DB00398 | Sorafenib | approved, investigational | yes | inhibitor | Details |
DB01268 | Sunitinib | approved, investigational | yes | inhibitor | Details |
DB04849 | Cediranib | investigational | unknown | | Details |
DB04879 | Vatalanib | investigational | unknown | | Details |
DB12307 | Foretinib | investigational | unknown | | Details |
DB05198 | CYC116 | investigational | unknown | | Details |
DB05014 | XL999 | investigational | unknown | | Details |
DB05075 | TG-100801 | investigational | unknown | | Details |
DB04727 | 1-{4-[4-Amino-6-(4-methoxyphenyl)furo[2,3-d]pyrimidin-5-yl]phenyl}-3-[2-fluoro-5-(trifluoromethyl)phenyl]urea | experimental | unknown | | Details |
DB05146 | XL820 | investigational | unknown | | Details |
DB06080 | Linifanib | investigational | unknown | | Details |
DB06101 | IMC-1C11 | investigational | unknown | | Details |
DB05931 | Pegdinetanib | investigational | unknown | | Details |
DB05984 | RAF-265 | investigational | unknown | | Details |
DB06436 | Semaxanib | investigational | unknown | | Details |
DB06589 | Pazopanib | approved | yes | inhibitor | Details |
DB06595 | Midostaurin | approved, investigational | yes | antagonistinhibitor | Details |
DB06626 | Axitinib | approved, investigational | yes | inhibitor | Details |
DB06938 | 4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide | experimental | unknown | | Details |
DB07183 | N-(4-phenoxyphenyl)-2-[(pyridin-4-ylmethyl)amino]nicotinamide | experimental | unknown | | Details |
DB07274 | N-cyclopropyl-6-[(6,7-dimethoxyquinolin-4-yl)oxy]naphthalene-1-carboxamide | experimental | unknown | | Details |
DB07326 | 6-chloro-N-pyrimidin-5-yl-3-{[3-(trifluoromethyl)phenyl]amino}-1,2-benzisoxazole-7-carboxamide | experimental | unknown | | Details |
DB07333 | N-(CYCLOPROPYLMETHYL)-4-(METHYLOXY)-3-({5-[3-(3-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-YL}AMINO)BENZENESULFONAMIDE | experimental | unknown | | Details |
DB07334 | N-[5-(ETHYLSULFONYL)-2-METHOXYPHENYL]-5-[3-(2-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-AMINE | experimental | unknown | | Details |
DB07514 | 3-(2-aminoquinazolin-6-yl)-1-(3,3-dimethylindolin-6-yl)-4-methylpyridin-2(1H)-one | experimental | unknown | | Details |
DB07528 | 3-(2-aminoquinazolin-6-yl)-4-methyl-1-[3-(trifluoromethyl)phenyl]pyridin-2(1H)-one | experimental | unknown | | Details |
DB07537 | N'-(6-aminopyridin-3-yl)-N-(2-cyclopentylethyl)-4-methyl-benzene-1,3-dicarboxamide | experimental | unknown | | Details |
DB08042 | N~4~-methyl-N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine | experimental | unknown | | Details |
DB08519 | N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine | experimental | unknown | | Details |
DB08875 | Cabozantinib | approved, investigational | yes | antagonist | Details |
DB08896 | Regorafenib | approved | yes | inhibitor | Details |
DB08901 | Ponatinib | approved, investigational | unknown | inhibitor | Details |
DB09078 | Lenvatinib | approved, investigational | yes | inhibitor | Details |
DB09079 | Nintedanib | approved | yes | inhibitor | Details |
DB05578 | Ramucirumab | approved, investigational | yes | antagonist | Details |
DB12010 | Fostamatinib | approved, investigational | unknown | inhibitor | Details |
DB12147 | Erdafitinib | approved, investigational | unknown | substrate | Details |
DB14840 | Ripretinib | approved | yes | inhibitor | Details |
DB15822 | Pralsetinib | approved, investigational | unknown | inhibitor | Details |
DB11800 | Tivozanib | approved, investigational | yes | inhibitor | Details |
DB16265 | Olinvacimab | investigational | yes | antibodyregulator | Details |
DB11679 | Fruquintinib | approved, investigational | yes | inhibitor | Details |